ArticleTheranostics2026

mRNA-dendritic cell antigen vaccine potentiates CD38 CAR-T Cell therapy for relapsed/refractory acute myeloid leukemia.

Yu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.